First patient on clinical trial thankful for UT MD Anderson
When Cindy Mette first received a colorectal cancer diagnosis from her doctor in Las Vegas, she never imagined that doctors halfway across the country would be comparing her to John Glenn. At the time, all she felt was disbelief.
She had noticed a drop in her energy, which led doctors to perform a colonoscopy in early 2022. Her doctors found and were later able to remove a colon tumor.
But less than a year after surgery,...
Weight loss injections and cancer: 6 questions, answered
Most people know that losing weight has numerous benefits, but making major lifestyle changes can be extremely difficult. For example, obese...
Radiation Planning Assistant: Delivering on the promise of AI
Adoption of radiation therapy technology has increased around the world to the point that access to the technology itself is often no longer...
23 cancer research highlights from the past year
Driven by our mission to end cancer, MD Anderson researchers developed new therapies, analyzed vast data sets, solved medical mysteries and more over the last year. These breakthroughs across the spectrum of cancer research can make immediate impacts on the lives of patients and shape the future of cancer care.
To expand the reach of these transformational breakthroughs, MD Anderson increased its visibility at national industry...
Is FLASH the future of radiation therapy?
Since radiation therapy was first used to treat cancer over a century ago, clinicians have sought the right balance between maximizing the...
The next generation of CDK inhibitors is coming
Since the discovery of cyclin-dependent kinases (CDKs), a family of proteins vital in the early stages of cell development, scientists have...
What is microsatellite instability?
When a patient receives a cancer diagnosis, one of the things their doctor might refer to is whether their cancer has microsatellite instability...